中生北控生物科技中期报告2024

GEM GEMGEMGEM GEMGEMGEM GEMGEM(1)(2) 356714161719202131 27 1866 http://www.zhongsheng.com.cn • CPA, CPA (U.S.) CPA, CFA H GEM8247H64,286,143HH1.00 H 1617 30600 HGEM HGEM ^) 2024IVD IVDIVD SinoCyte 1.3381.3913.8% 5,8506,67012.3%44%48%) 3,1603,0702.9% 2,2302,58013.6% 1,6901,6005.6%r-GCANA502-9 1,830800 IVDIVD2023IVD58.55IVD6%202879.62023–20286IVD3.8% IVDIVDIVD 8,820 2,1002206,9701,1702,0402,000 21050250440 1,300 5545305,2104,770 *52,475,00065,680,000 1. 2. 161177 3. 92% 11,100,0008% 4. 5. 1,562,0001,542,000(a)1,197,0001,179,000(b)296,000296,000(c)49,00049,000(d)20,00018,000 6. 25% 15% 6. 7. 144,707,176144,707,176 8. 9. 346712122 10. 346712122 3090 11. 12. 80,421,03380,421,033164,286,14364,286,143H1 13. 6,000,00010,000,000 14. 20500,0004,250,0004,000,000 15. (a) 15. (b) 15. (i)14 (ii)2008% (iii)19%1,500,000 16. 571XV352GEM5.465.68 352GEM5.465.68 XV23336 1.36.01%36.01%H 2.43.12%H 3.99.5% 4.77.94% 5. XV23336 GEM GEM GEM5.485.67GEM GEM GEMC1 D.2.5 D.2.5(i)GEM(ii) GEM (i)16.9918.69GEM(ii)5.055.56GEM(iii)1.611.77GEM20.74 GEMGEM 51%GEM GEM17.50A(1) GEM17.50A(1)